SCHEMBL7066532

SCHEMBL7066532

OC1CCN(Cc2ccc(-c3ccc(Cl)cc3)c(Oc3ccccc3)c2)CC1

nearest known ligand 0.61

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 2/20 0.52
NPC1 O15118 1/20 0.52
LMNA P02545 1/20 0.48
MEN1 O00255 3/20 0.48
KMT2A Q03164 3/20 0.48
ALDH1A1 P00352 3/20 0.47
MCHR1 Q99705 2/20 0.47
HTR2A P28223 1/20 0.47
LTA4H P09960 1/20 0.47
CCR5 P51681 1/20 0.47
SIGMAR1 Q99720 2/20 0.46
BCHE P06276 1/20 0.44
ACHE P22303 1/20 0.44
BACE1 P56817 1/20 0.44
CYP2D6 P10635 1/20 0.44
S1PR5 Q9H228 1/20 0.44
PDCD1 Q15116 1/20 0.44
CD274 Q9NZQ7 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL668624 0.85 ABCB1 (0.52) RAB9AMEN1KMT2AALDH1A1MCHR1
SCHEMBL7067262 0.84 SIGMAR1 (0.55) MCHR1HTR2ALTA4HCCR5SIGMAR1
SCHEMBL24008595 0.80 RAB9A (0.72) RAB9ANPC1MEN1KMT2AALDH1A1
SCHEMBL4141085 0.77 ALDH1A1 (0.60) RAB9ANPC1MEN1KMT2AALDH1A1
SCHEMBL24008985 0.76 RAB9A (0.64) RAB9ANPC1MEN1KMT2AALDH1A1
SCHEMBL668374 0.75 PDE4B (0.61) LMNAMEN1KMT2ABCHEACHE
SCHEMBL669902 0.74 MEN1 (0.58) RAB9AMEN1KMT2AALDH1A1MCHR1
SCHEMBL5163291 0.73 ALDH1A1 (0.47) RAB9ANPC1MEN1KMT2AALDH1A1
SCHEMBL668404 0.73 MEN1 (0.47) RAB9AMEN1KMT2AALDH1A1CYP2D6
SCHEMBL669387 0.73 GRM2 (0.53) MEN1KMT2AALDH1A1BCHEACHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2003037271-A2 COMPOUNDS, PHARMACEUTICAL COMPOSITIONS AND METHODS OF USE THEREFOR MILLENNIUM PHARMACEUTICALS,INC. (US) 2003-05-08 WO disclosed